Sesamol alleviates diet-induced cardiometabolic syndrome in rats via up-regulating PPARγ, PPARα and e-NOS

Journal of Nutritional Biochemistry

Volumn 23, Issue 11, 2012, Pages 1482-1489

  Sharma, Ashok Kumar ^a   Bharti, Saurabh ^a   Bhatia, Jagriti ^a   Nepal, Saroj ^a   Malik, Salma ^a   Ray, Ruma ^a   Kumari, Santosh ^b   Arya, Dharamvir Singh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN AGRICULTURAL RESEARCH INSTITUTE   (India)

Author keywords

Cardiometabolic syndrome; E NOS; Insulin resistance; PPAR ; SERBP 1c; Sesamol

Indexed keywords

3 NITROTYROSINE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEPTIN; LIVER X RECEPTOR ALPHA; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; RESISTIN; SESAMOL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CARDIOMETABOLIC SYNDROME; CELL ULTRASTRUCTURE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DOSE RESPONSE; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY LIVER; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID DIET; LIVER; LIVER CELL; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; ANTIOXIDANTS; BENZODIOXOLES; BODY WEIGHT; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSLIPIDEMIAS; FATTY LIVER; HEPATOCYTES; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PHENOLS; PPAR ALPHA; PPAR GAMMA; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UP-REGULATION;

RATTUS; SESAMUM INDICUM;

EID: 84867726097     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.09.011     Document Type: Article

References (28)

1. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
2. Shoelson S.E., Herrero L., Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007, 132:2169-2180.
3. Hopps E., Noto D., Caimi G., Averna M.R. A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis 2010, 20:72-77.
4. Roberts C.K., Vaziri N.D., Barnard R.J. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 2002, 106:2530-2532.
5. Roberts C.K., Vaziri N.D., Wang X.Q., Barnard R.J. Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension 2000, 36:423-429.
6. Otani H. Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 2010, [Epub ahead of print].
7. Ferré P., Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 2010, 12:83-92.
8. Fan J.G., Qiao L. Commonly used animal models of non-alcoholic steatohepatitis. Hepatobiliary Pancreat Dis Int 2009, 8:233-240.
9. Sundaresan S., Vijayagopal P., Mills N., Imrhan V., Prasad C. A mouse model for nonalcoholic steatohepatitis. J Nutr Biochem 2010, [Epub ahead of print].
10. Nepal S, Malik S, Sharma AK, Bharti S, Kumar N, Siddiqui KM, et al. Abresham ameliorates dyslipidemia, hepatic steatosis and hypertension in high-fat diet fed rats by repressing oxidative stress, TNF-α and normalizing NO production. 2011 [Epub ahead of print].
11. Shin S.J., Lim J.H., Chung S., Youn D.Y., Chung H.W., Kim H.W., et al. Peroxisome proliferator-activated receptor-alpha activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats. Hypertens Res 2009, 32:835-845.
12. Chopra K., Tiwari V., Arora V., Kuhad A. Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy. J Pain 2010, 11:950-957.
13. Chu P.Y., Chien S.P., Hsu D.Z., Liu M.Y. Protective effect of sesamol on the pulmonary inflammatory response and lung injury in endotoxemic rats. Food Chem Toxicol 2010, 48:1821-1826.
14. Ying Z., Kherada N., Kampfrath T., Mihai G., Simonetti O., Desikan R., et al. A modified sesamol derivative inhibits progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2010, [Epub ahead of print].
15. Okhawa H., Oohishi N., Yagi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
16. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47:469-474.
17. Lawrence R.A., Burk R.F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976, 71:952-958.
18. Bradford M.M. A rapid and sensitive method for quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
19. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Sabio G., Davis R.J. cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Trends Biochem Sci 2010, 35:490-496.
21. Yki-Jarvinen H. Thiazolidinediones. Drug Ther 2004, 351:1106-1118.
22. Ding L., Jin D., Chen X. Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes. J Nutr Biochem 2010, 21:941-947.
23. Michalik L., Wahli W. Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest 2006, 116:598-606.
24. Cornick C.L., Strongitharm B.H., Sassano G., Rawlins C., Mayes A.E., Joseph A.N., et al. Identification of a novel agonist of peroxisome proliferator-activated receptors alpha and gamma that may contribute to the anti-diabetic activity of guggulipid in Lep(ob)/Lep(ob) mice. J Nutr Biochem 2009, 20:806-815.
25. Yang J., Park Y., Zhang H., Xu X., Laine G.A., Dellsperger K.C., et al. Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 2009, 296:H1850-H1858.
26. Kammoun H.L., Chabanon H., Hainault I., Luquet S., Magnan C., Koike T., et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 2009, 119:1201-1215.
27. Taskinen M.R. Diabetic dyslipidemia: from basic research to clinical practice. Diabetologia 2003, 46:733-749.
28. Chandrasekaran V.R., Chien S.P., Hsu D.Z., Liu M.Y. Anti-hepatotoxic effects of 3,4-methylenedioxyphenol and N-acetylcysteine in acutely acetaminophen-overdosed mice. Hum Exp Toxicol 2011, [Epub ahead of print].